Related Experiment Videos

Rationality and methods: registry of clinical practice in high-risk cardiovascular patients

Luiz Alberto Piva E Mattos1

  • 1Sociedade Brasileira de Cardiologia, Rio de Janeiro, RJ, Brasil. lmattos@cardiol.br

Insights

This study establishes the first Brazilian registry to assess high-risk cardiovascular patient care, identifying key areas for improving evidence-based interventions in clinical practice.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Research

Background:

  • No existing Brazilian registry documents clinical practice for high-risk cardiovascular patients.
  • This study aims to identify gaps in evidence-based intervention incorporation.

Purpose of the Study:

  • To record Brazilian clinical practice for patients at high cardiovascular risk.
  • To establish a nationwide perspective on cardiovascular disease management.

Main Methods:

  • Prospective observational registry-type study.
  • Inclusion criteria: established cardiovascular disease or >=3 risk factors (hypertension, smoking, dyslipidemia, age >70, CKD, family history, carotid disease).
  • Data collected from 43 centers (public/private hospitals, health units) over one year.

Main Results:

  • Findings to be presented one year after data collection begins (September 2011).
  • Results will be consolidated after a meeting to discuss study objectives.

Conclusions:

  • Analysis of this multicenter registry will provide a comprehensive view of cardiovascular disease treatment in Brazil.
  • This initiative aims to improve patient outcomes through better clinical practice.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...